ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01116635
Recruitment Status : Completed
First Posted : May 5, 2010
Last Update Posted : March 17, 2014
Sponsor:
Information provided by (Responsible Party):
University of British Columbia

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2012
  Actual Study Completion Date : January 2012